2. Search Result
Search Result
Results for "

Silymarin

" in MedChemExpress (MCE) Product Catalog:

10

Inhibitors & Agonists

5

Natural
Products

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-N7073
    Silymarin
    5 Publications Verification

    		 SARS-CoV Infection Neurological Disease Inflammation/Immunology Cancer
    Silymarin is an extract of the milk thistle (Silybum marianum). Silymarin is an effective SARS-CoV-2 main protease (M pro) inhibitor. Silymarin can significantly reduce tumor cell proliferation, angiogenesis as well as insulin resistance. Silymarin has the chemopreventive effect on hepatocellular carcinoma (HCC). Silymarin has the potential for COVID-19 research .
    Silymarin
  • HY-W043277
    m-PEG3-Tos

    		PROTAC Linkers Cancer
    m-PEG3-Tos is a PEG-based PROTAC linker can be used in the synthesis of Silymarin (HY-W043277) .
    m-PEG3-Tos
  • HY-N7046
    Silybin B

    Silibinin B

    		 Amyloid-β Neurological Disease Cancer
    Silybin B (Silibinin B), a flavonolignan separated from Silybum marianum, has anti-tumor activity. Silybin B is the most potent antifibrillogenic and anti-oligomeric component of silymarin and proposes it as a promising anti Alzheimer’s disease agent candidate .
    Silybin B
  • HY-N7043
    Isosilybin A
    2 Publications Verification

    		 Apoptosis Cancer
    Isosilybin A, a flavonolignan isolated from silymarin, has anti-prostate cancer (PCA) activity. Isosilybin A inhibits proliferation and induces G1 phase arrest and apoptosis in cancer cells, which activates apoptotic machinery in PCA cells via targeting Akt-NF-κB-androgen receptor (AR) axis .
    Isosilybin A
  • HY-114661
    m-PEG4-Tos

    		PROTAC Linkers Cancer
    m-PEG4-Tos is a derivative of silybin ethers, extracted from patent CN105037337A (compound III-b). m-PEG4-Tos is a PEG-based PROTAC linker can be used in the synthesis of Silymarin (HY-W043277) .
    m-PEG4-Tos
  • HY-N13245
    Milk Thistle Extract

    		SARS-CoV Others
    Milk Thistle Extract is the extract of Milk Thistle, with content of 80% Silymarin.
    Milk Thistle Extract
  • HY-W042501
    m-PEG5-Tos

    		PROTAC Linkers Cancer
    m-PEG5-Tos is a derivative of silybin ethers, extracted from patent CN105037337A (compound III-c). m-PEG5-Tos is a PEG-based PROTAC linker can be used in the synthesis of Silymarin (HY-W043277) .
    m-PEG5-Tos
  • HY-135090
    m-PEG8-Tos

    		PROTAC Linkers Cancer
    Tos-PEG8-m is a derivative of silybin ethers, extracted from patent CN105037337A (compound III-d). Tos-PEG8-m is a PEG-based PROTAC linker can be used in the synthesis of Silymarin (HY-W043277) .
    m-PEG8-Tos
  • HY-N7046R
    Silybin B (Standard)

    		Amyloid-β Neurological Disease Cancer
    Silybin B (Standard) is the analytical standard of Silybin B. This product is intended for research and analytical applications. Silybin B (Silibinin B), a flavonolignan separated from Silybum marianum, has anti-tumor activity. Silybin B is the most potent antifibrillogenic and anti-oligomeric component of silymarin and proposes it as a promising anti Alzheimer’s disease agent candidate .
    Silybin B (Standard)
  • HY-N7043R
    Isosilybin A (Standard)

    		Apoptosis Cancer
    Isosilybin A (Standard) is the analytical standard of Isosilybin A. This product is intended for research and analytical applications. Isosilybin A, a flavonolignan isolated from silymarin, has anti-prostate cancer (PCA) activity. Isosilybin A inhibits proliferation and induces G1 phase arrest and apoptosis in cancer cells, which activates apoptotic machinery in PCA cells via targeting Akt-NF-κB-androgen receptor (AR) axis .
    Isosilybin A (Standard)

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: